CD2 and diffuse large B-cell lymphoma: Among a cohort of patients who received tandem CAR-T-cell therapy for diffuse large B-cell lymphoma, we noted that CD2 expression levels in those with treatment resistance were slightly lower than those in patients who achieved complete remission, although this difference did not reach statistical significance (Fig. 1E).